The clinical use of enfortumab vedotin and pembrolizumab in patients with advanced urothelial carcinoma: Using clinical judgement over treatment criteria Journal Article
| Authors: | Apolo, A. B.; Bellmunt, J.; Cordes, L.; Gupta, S.; Powles, T.; Rosenberg, J. E.; Van Der Heijden, M. S. |
| Article Title: | The clinical use of enfortumab vedotin and pembrolizumab in patients with advanced urothelial carcinoma: Using clinical judgement over treatment criteria |
| Keywords: | cancer chemotherapy; cancer survival; treatment response; overall survival; cancer patient; letter; progression free survival; transitional cell carcinoma; overall response rate; human; pembrolizumab; enfortumab vedotin |
| Journal Title: | ESMO Open |
| Volume: | 9 |
| Issue: | 9 |
| ISSN: | 2059-7029 |
| Publisher: | European Society for Medical Oncology |
| Date Published: | 2024-09-01 |
| Start Page: | 103725 |
| Language: | English |
| DOI: | 10.1016/j.esmoop.2024.103725 |
| PROVIDER: | scopus |
| PMCID: | PMC11408050 |
| PUBMED: | 39236601 |
| DOI/URL: | |
| Notes: | Letter -- Source: Scopus |
